Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials

Published:2016-01 Issue:1 Volume:118 Page:112-117
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Musunuru H Bindu,Quon Harvey,Davidson Melanie,Cheung Patrick,Zhang Liying,D’Alimonte Laura,Deabreu Andrea,Mamedov Alexandre,Loblaw Andrew

Funder

Abbott-Canadian Association

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference39 articles.

1. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013;Amin;Appl Health Econ Health Policy,2014

2. Stereotactic body radiotherapy for prostate cancer;Henderson;Clin Oncol,2015

3. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results;Madsen;Int J Radiat Oncol Biol Phys,2007

4. Clinical trials of stereotactic ablative radiotherapy for prostate cancer: updates and future direction;Musunuru;Future Oncol,2015

5. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes;Loblaw;Radiother Oncol,2013

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients;Frontiers in Oncology;2024-02-01

2. The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?;World Journal of Urology;2023-11-03

3. Dosimetric evaluation of inclusion of proximal seminal vesicle in target volume in low-risk prostate cancer treated with stereotactic body radiotherapy;Anatolian Current Medical Journal;2023-07-28

4. Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique;Cancer/Radiothérapie;2023-06

5. Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study;Acta Oncologica;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3